Masayuki Sugimoto Selected Research

Masayuki Sugimoto Research Topics

Disease

6	Aneurysm (Aneurysms) 11/2022 - 10/2012
5	Endoleak 04/2022 - 02/2017
5	Obesity 12/2020 - 12/2008
5	Abdominal Aortic Aneurysm 11/2019 - 01/2015
4	Neoplasms (Cancer) 10/2020 - 04/2004
3	Chronic Limb-Threatening Ischemia 01/2022 - 02/2015
3	Stroke (Strokes) 08/2017 - 01/2015
3	Insulin Resistance 08/2016 - 12/2008
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2010 - 12/2008
3	Inflammation (Inflammations) 03/2010 - 12/2008
3	Body Weight (Weight, Body) 03/2010 - 12/2008
2	Iliac Aneurysm 11/2022 - 07/2018
2	Rupture 07/2021 - 11/2020
2	Thrombosis (Thrombus) 01/2021 - 07/2020
2	Atherosclerosis 01/2016 - 06/2009
2	Type 2 Diabetes Mellitus (MODY) 02/2015 - 12/2008
2	Hyperplasia 01/2009 - 10/2005
1	Malnutrition (Nutritional Deficiencies) 01/2022
1	Sarcopenia 01/2022
1	Chronic Renal Insufficiency 07/2021
1	Spinal Cord Ischemia 01/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2020
1	Fibrosis (Cirrhosis) 12/2020
1	Aortic Dissection 11/2020
1	Carcinogenesis 10/2020
1	Liver Neoplasms (Liver Cancer) 10/2020
1	Varicose Veins (Varicose Vein) 07/2020
1	Hypertrophy 03/2018
1	Gout 01/2018
1	Hypertension (High Blood Pressure) 08/2017
1	Obstructive Lung Diseases (Obstructive Lung Disease) 08/2017
1	Paraplegia (Spastic Paraplegia) 07/2016
1	Aortic Arch Aneurysm 07/2016
1	Hypercholesterolemia 07/2016
1	Dyslipidemias (Dyslipidemia) 01/2016
1	Fatty Liver 01/2016
1	Ischemia 02/2015
1	Hemorrhage 01/2015
1	Delirium 01/2015
1	Hyperlipidemias (Hyperlipidemia) 01/2015
1	Sepsis (Septicemia) 10/2012
1	Compartment Syndromes 10/2012

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 01/2018 - 12/2008
3	phosphatidylcholine-ceramide phosphocholine transferaseIBA 12/2020 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 02/2015 - 12/2008
2	Indicators and Reagents (Reagents)IBA 01/2022 - 04/2004
2	ZincIBA 01/2022 - 02/2020
2	LipidsIBA 12/2020 - 03/2010
2	SphingomyelinsIBA 12/2020 - 01/2016
2	propagermanium (Ge 132)IBA 03/2010 - 12/2008
2	CC ChemokinesIBA 03/2010 - 12/2008
2	Triglycerides (Triacylglycerol)IBA 03/2010 - 12/2008
2	rho-Associated KinasesIBA 01/2009 - 10/2005
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2009 - 10/2005
1	Amino Acids FDA Link 12/2020
1	Carbon Tetrachloride (Tetrachloromethane)IBA 12/2020
1	Choline (Choline Chloride)IBA 12/2020
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 12/2020
1	Phosphotransferases (Kinase)IBA 10/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020
1	Febuxostat FDA Link 01/2018
1	Uric Acid (Urate)IBA 01/2018
1	Colchicine FDA LinkGeneric 01/2018
1	CreatinineIBA 08/2017
1	Atorvastatin (Lipitor)FDA Link 07/2016
1	oxidized low density lipoproteinIBA 07/2016
1	alirocumabIBA 07/2016
1	LDL CholesterolIBA 07/2016
1	Cholesterol Ester Transfer ProteinsIBA 01/2016
1	ApolipoproteinsIBA 01/2016
1	SphingolipidsIBA 01/2016
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2016
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2016
1	EnzymesIBA 01/2016
1	HDL CholesterolIBA 01/2016
1	Lipoproteins (Lipoprotein)IBA 01/2016
1	CeramidesIBA 01/2016
1	Metformin (Glucophage)FDA LinkGeneric 02/2015
1	NitrogenIBA 01/2015
1	Urea (Carbamide)FDA LinkGeneric 01/2015
1	CholesterolIBA 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2012
1	Messenger RNA (mRNA)IBA 03/2010
1	Biomarkers (Surrogate Marker)IBA 03/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2010
1	Pioglitazone (Actos)FDA Link 06/2009
1	AdipokinesIBA 06/2009
1	Apolipoproteins E (ApoE)IBA 06/2009

Therapy/Procedure

12	Endovascular Aneurysm Repair 04/2022 - 01/2015
1	Aftercare (After-Treatment) 11/2022
1	Renal Replacement Therapy (Therapies, Renal Replacement) 07/2021
1	Sclerotherapy 07/2020
1	Laser Therapy (Surgery, Laser) 07/2020
1	Prostheses and Implants (Prosthesis) 07/2018
1	Hip Replacement Arthroplasty (Total Hip Replacement) 03/2018
1	Therapeutics 01/2018
1	Renal Dialysis (Hemodialysis) 08/2017
1	Stents 02/2017
1	Length of Stay 01/2015
1	Fasciotomy 10/2012